ENDOTHELIN RECEPTORS AND CALCIUM SIGNALING

被引:228
作者
POLLOCK, DM [1 ]
KEITH, TL [1 ]
HIGHSMITH, RF [1 ]
机构
[1] UNIV CINCINNATI,COLL MED,DEPT MOLEC & CELLULAR PHYSIOL,CINCINNATI,OH 45267
关键词
CALCIUM; ENDOTHELIAL CELLS; VASCULAR SMOOTH MUSCLE; SIGNAL TRANSDUCTION;
D O I
10.1096/fasebj.9.12.7672512
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin (ET) is a potent vasoactive peptide produced by endothelial cells that elicits prolonged constriction in most smooth mascle preparations and dilation in others, Of three isopeptides, ET-1 is the only form constitutively released and may modulate vascular tone via binding to one of several receptor subtypes in smooth muscle. Activation of the ET(A) receptor is associated with pronounced vasoconstriction whereas ET(B) receptor occupation is linked to vasodilation. In addition, other subtypes of the ET(B) receptor exist, one mediating vasodilation (ET(B1)) and the other eliciting constriction (ET(B2)). An additional receptor subtype, ET(c), has been identified although its physiological significance is uncertain. Distribution of these receptors varies between species and among tissue types, although it has been generally observed that ETA receptors predominate in arterial vessels whereas ET(B) receptors predominate on the low pressure side of the circulation. In vascular smooth muscle, an increase in intracellular Ca2+ is a common feature occurring after activation of all receptor subtypes, Upon binding of ET-1 to ET(A), phospholipase C is activated and inositol triphosphate is generated, Ca2+ is then released from intracellular stores accompanied by the influx of extracellular Ca2+ and activation of the contractile machinery. The precise mechanism by which ET-1 affects intracellular Ca2+ regalation is not fully understood, but most likely involves multiple ion channels, protein kinases, and other intracellular mediators. The events coupled to non-ET(A) receptor signaling are poorly understood.
引用
收藏
页码:1196 / 1204
页数:9
相关论文
共 55 条
[1]   A SPECIFIC ENDOTHELIN-1 ANTAGONIST BLOCKS INHALED ENDOTHELIN-1-INDUCED BRONCHOCONSTRICTION IN SHEEP [J].
ABRAHAM, WM ;
AHMED, A ;
CORTES, A ;
SPINELLA, MJ ;
MALIK, AB ;
ANDERSEN, TT .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (05) :2537-2542
[2]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[3]  
ARAMORI I, 1992, J BIOL CHEM, V267, P12468
[4]   DISCRIMINATION BETWEEN ETA-RECEPTOR-MEDIATED AND ETB-RECEPTOR-MEDIATED EFFECTS OF ENDOTHELIN-1 AND [ALA1,3,11,15]ENDOTHELIN-1 BY BQ-123 IN THE ANESTHETIZED RAT [J].
BIGAUD, M ;
PELTON, JT .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :912-918
[5]   ENDOTHELIN SARAFOTOXIN RECEPTOR HETEROGENEITY - EVIDENCE FOR DIFFERENT GLYCOSYLATION IN RECEPTORS FROM DIFFERENT TISSUES [J].
BOUSSOMITTLER, D ;
GALRON, R ;
SOKOLOVSKY, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) :921-926
[6]   ENDOTHELIN INDUCES A NONSELECTIVE CATION CURRENT IN VASCULAR SMOOTH-MUSCLE CELLS [J].
CHEN, C ;
WAGONER, PK .
CIRCULATION RESEARCH, 1991, 69 (02) :447-454
[7]   THE ENDOTHELIN ET(B) RECEPTOR MEDIATES BOTH VASODILATION AND VASOCONSTRICTION INVIVO [J].
CLOZEL, M ;
GRAY, GA ;
BREU, V ;
LOFFLER, BM ;
OSTERWALDER, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :867-873
[8]  
COLIGORSKY M, 1994, J CELL PHYSL, V158, P485
[9]   MEDIATION VIA DIFFERENT RECEPTORS OF THE VASOCONSTRICTOR EFFECTS OF ENDOTHELINS AND SARAFOTOXINS IN THE SYSTEMIC CIRCULATION AND RENAL VASCULATURE OF THE ANESTHETIZED RAT [J].
CRISTOL, JP ;
WARNER, TD ;
THIEMERMANN, C ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :776-779
[10]   HUMAN ENDOTHELIN RECEPTORS CHARACTERIZED USING REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION, IN-SITU HYBRIDIZATION, AND SUBTYPE-SELECTIVE LIGANDS BQ123 AND BQ3020 - EVIDENCE FOR EXPRESSION OF ET(B)-RECEPTORS IN HUMAN VASCULAR SMOOTH-MUSCLE [J].
DAVENPORT, AP ;
OREILLY, G ;
MOLENAAR, P ;
MAGUIRE, JJ ;
KUC, RE ;
SHARKEY, A ;
BACON, CR ;
FERRO, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S22-S25